General disorders and administration site conditions

Papers on general disorders and administration site conditions

4 papers

Friday, September 11

Frontiers in PharmacologySep 11

Reporting patterns of suicide- and self-injury-related events involving liraglutide, semaglutide, and tirzepatide: data from the European pharmacovigilance database

Flowchart of the included individual case safety reports.

Study of 42,941 peoplePopulations

Wednesday, November 6

Frontiers in PharmacologyNov 6

Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and sex-specific subgroups

Study of 37,827 peopleTirzepatide

Friday, June 7

Frontiers in PharmacologyJun 7

A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database

Study in peopleTirzepatide

Tuesday, December 13

Frontiers in PharmacologyDec 13

Real-world safety of PCSK9 inhibitors: A pharmacovigilance study based on spontaneous reports in FAERS

Study in peoplePCSK9 inhibitors